DaVita Inc

DVA remains in a Stage 2 advancing regime with an intact long-term uptrend. The active Parabola pattern indicates trend acceleration driven by strong demand, but current price is extended into overbought extremes near resistance. Medium-term bias remains bullish, yet short-term timing is neutral. Aligned with the Free Cash Flow + Buybacks strategy, we will stalk for pullbacks into the rising EMA support zone rather than chase extended strength.

• ↑Q4 2025 adj. operating income $586M and EPS $3.40
• ↑2026 EPS guidance raised to $14.10–$15.20 range
• ↓Q4 2025 treatment volumes fell 1.1% YoY